House Democrats start probe into MS drug prices
The dispute became the center of a drug price firestorm.
Teva said weak U.S. markets and the ongoing political turmoil in Venezuela weighed on the company's second quarter performance.
Sanofi is starting to offset diabetes franchise losses
Upbeat guidance from Target inspires retail rally.